Labajo, Lemuel Mar A.
HRN: 17-06-62 Sex: MalePatient Encounter
Audit Details
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
03/06/2024
METRONIDAZOLE 5MG/ML, 100ML (VIAL)
03/06/2024
03/19/2024
IV
500mg
Q8
Typhoid Fever
Waiting Final Action
Indication: Empiric Type of Infection: BloodstreamIntra-abdominal Compliance to guidelines: Compliant To Guidelines
Initial appropriateness: Yes
Final appropriateness: Yes
Overall appropriateness: Yes